Has Edwin Kingsley, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,182,479 in general payments to Edwin Kingsley, MD across 1,313 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Edwin Kingsley, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Edwin Kingsley, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Edwin Kingsley, MD

Hematology & Oncology · Las Vegas, NVNPI 1336156199

Payments from drug & device makers

$9,182,479in general payments, 2019–2025

Across 1,313 payments — averaging $6993.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Beigene, Ltd.$6.3M
Pfizer$1M
Incyte Corporation$435K
Seagen Inc.$367K
Beone Medicines Ltd.$272K
Sumitomo Pharma America, Inc.$148K
plus $675K from 36 others

$5,533in research payments, 2019–2025

Across 4 payments — averaging $1383.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$4K
Pharmacyclics LLC, An Abbvie Company$1K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Beigene, Ltd.	386	$6,258,478
Pfizer	78	$1,026,483
Incyte Corporation	254	$435,286
Seagen Inc.	78	$366,593
Beone Medicines Ltd.	26	$272,465
Sumitomo Pharma America, Inc.	36	$147,968
Takeda Pharmaceuticals U.S.A., Inc.	40	$146,650
Secura Bio, Inc.	20	$105,548
Genentech, Inc.	28	$102,590
Merck	9	$68,413
ADC Therapeutics America, Inc.	8	$58,060
Beigene USA, Inc.	30	$43,562
Beone Medicines USA, Inc.	15	$28,157
Bayer	9	$24,655
TG Therapeutics, Inc.	9	$24,643
Pharmacyclics LLC, An Abbvie Company	21	$22,915
Bristol Myers Squibb	8	$13,879
Sanofi US Services Inc.	1	$12,050
Verastem, Inc.	1	$11,500
AstraZeneca	2	$7,269
Novartis	58	$1,715
Daiichi Sankyo Inc.	137	$1,308
E.r. Squibb & Sons, L.L.C.	5	$481
Johnson & Johnson	7	$296
Lilly USA, LLC	2	$243
Sirtex Medical Inc	2	$164
Boston Scientific	1	$150
Servier Pharmaceuticals LLC	7	$147
Genentech USA, Inc.	3	$119
Sanofi	5	$113
Amgen	6	$112
EMD Serono, Inc.	4	$76
Sobi, Inc	3	$62
Exelixis Inc.	2	$55
Astellas Pharma US Inc	3	$53
Regeneron Healthcare Solutions, Inc.	2	$52
Apellis Pharmaceuticals, Inc.	1	$51
GSK	2	$40
Agios Pharmaceuticals, Inc.	1	$22
Morphosys, US Inc.	1	$19
Forte Bio-pharma LLC	1	$18
Eisai Inc.	1	$17

How this compares

$9,182,479 in reported general payments places this provider in the 95th percentile of 82 hematology & oncology providers in Nevada.

See all hematology & oncology providers in Nevada →

Medicare billing

Part B allowed, 2024

$3,909,744

Medicare patients

949

Services billed

187,442

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Las Vegas

Nicholas VogelzangLas Vegas$8.3M
Oscar GoodmanLas Vegas$6M
Khawaja JahangirLas Vegas$2.5M
Carolyn MulroneyLas Vegas$1.5M
Wolfram SamlowskiLas Vegas$1.1M
Anuradha ThummalaLas Vegas$736K
Grzegorz ObaraLas Vegas$668K
Aaron GoodmanLas Vegas$480K
Vikas GuptaLas Vegas$300K
Clark JeanLas Vegas$162K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →